Meeting
2020 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients.
Authors
Fumiaki Watanabe
Jichi Medical University, Saitama, Japan
Fumiaki Watanabe , Koichi Suzuki , Toshiki Rikiyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 745)
Abstract #
745
Poster Bd #
M12
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and serum of pancreatic cancer patients.
First Author: Fumiaki Watanabe
Poster
2017 Gastrointestinal Cancers Symposium
The clinical significance of KRAS monitoring in tumor tissues and blood of patients with pancreatic tumor.
First Author: Fumiaki Watanabe
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Multicenter study of circulating tumor DNA in patients with pancreatic cancer using a personalized panel: ARTEMIS-PC prospective observational trial.
First Author: Edward D. Esplin
Poster
2016 Gastrointestinal Cancers Symposium
Liquid biopsy leads to a paradigm shift in cancer treatment.
First Author: Koichi Suzuki